Several preclinical studies have demonstrated that endothelial cells (ECs), a key component of the tumor microenvironment, promote cancer cell survival by secreting soluble factors in a paracrine fashion, which in turn activate cancer-promoting signaling pathways such as AKT, NF-κB and epithelial-mesenchymal transition pathway [8, 9]. Here, AKT1 is linked to cancer.